A Pinch of Artificial Sweetener, Please?

Just how much is too much? Our bodies are designed to crave sugary treats. “Sugar is a deep, deep ancient craving,” – Daniel …

Lilly to Donate Insulin KwikPens To Support Lower-Income Communities

Starting this month, Eli Lilly and Company will donate at least 200,000 KwikPens® to three relief organizations – Americares, Direct Relief and …

Invokana® Gets New Indication in Canada to Reduce Risks with Diabetic Kidney Disease

Health Canada has approved Invokana® (canagliflozin) as an adjunct to diet, exercise, and standard-of-care therapy, to reduce the risk of end-stage …

US FDA Approves Only Triple-Combo Tablet with Jardiance® for Adults with T2D

The U.S. Food and Drug Administration has approved Trijardy™ XR to lower blood sugar in adults with Type 2 diabetes, along with diet and …

State of Illinois Passes Legislation to Cap Monthly Insulin Co-Pays

Governor J.B. Pritzker signed legislation that will cap insulin co-pays in the state of Illinois last week. The legislation, Senate Bill 667 (SB …

Diabetes Screening At the Barber Shop Maybe Beneficial for African Americans

It turns out that getting a hair cut maybe a good time for African Americans to also get a blood glucose screening, according to a new study. The …

AADE Rebrands as Association of Diabetes Care & Education Specialists (ADCES)

The American Association of Diabetes Educators announced that the organization has changed its name to reflect the association’s shift to a …

FDA approves Ozempic® for Heart Problems in Adults with T2D

The U.S. Food and Drug Administration (FDA) has approved a new indication for Novo Nordisk’s Ozempic® (semaglutide) injection 0.5 mg or 1 mg …

Tandem Launches the t:slim X2 Insulin Pump with Control-IQ Tech. in the U.S.

Tandem Diabetes Care, Inc. today announced the commercial launch of the t:slim X2™ insulin pump with Control-IQ™ technology, an …

Behavior Change Company Raises $21M to Roll Out Digital Diabetes Treatment in Europe

Oviva, a digital provider of Type 2 diabetes treatment in Europe, has raised $21 million in Series B funding. The new capital will be used to further …